These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29788487)

  • 1. The Effects of Metformin and Weight Loss on Biomarkers Associated With Breast Cancer Outcomes.
    Patterson RE; Marinac CR; Sears DD; Kerr J; Hartman SJ; Cadmus-Bertram L; Villaseñor A; Flatt SW; Godbole S; Li H; Laughlin GA; Oratowski-Coleman J; Parker BA; Natarajan L
    J Natl Cancer Inst; 2018 Nov; 110(11):1239-1247. PubMed ID: 29788487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recruitment strategies, design, and participant characteristics in a trial of weight-loss and metformin in breast cancer survivors.
    Patterson RE; Marinac CR; Natarajan L; Hartman SJ; Cadmus-Bertram L; Flatt SW; Li H; Parker B; Oratowski-Coleman J; Villaseñor A; Godbole S; Kerr J
    Contemp Clin Trials; 2016 Mar; 47():64-71. PubMed ID: 26706665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of metformin and lifestyle intervention on adipokines and hormones in breast cancer survivors: a pooled analysis from two randomized controlled trials.
    Johansson H; Bellerba F; Macis D; Bertelsen BE; Guerrieri-Gonzaga A; Aristarco V; Viste K; Mellgren G; Di Cola G; Costantino J; Scalbert A; Sears DD; Gandini S; DeCensi A; Bonanni B
    Breast Cancer Res Treat; 2024 May; 205(1):49-59. PubMed ID: 38279016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective Randomized Biomarker Study of Metformin and Lifestyle Intervention for Prevention in Obese Women at Increased Risk for Endometrial Cancer.
    Yates MS; Coletta AM; Zhang Q; Schmandt RE; Medepalli M; Nebgen D; Soletsky B; Milbourne A; Levy E; Fellman B; Urbauer D; Yuan Y; Broaddus RR; Basen-Engquist K; Lu K
    Cancer Prev Res (Phila); 2018 Aug; 11(8):477-490. PubMed ID: 29716897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body weight management in overweight and obese breast cancer survivors.
    Shaikh H; Bradhurst P; Ma LX; Tan SYC; Egger SJ; Vardy JL
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012110. PubMed ID: 33305350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of metformin vs placebo on and metabolic factors in NCIC CTG MA.32.
    Goodwin PJ; Parulekar WR; Gelmon KA; Shepherd LE; Ligibel JA; Hershman DL; Rastogi P; Mayer IA; Hobday TJ; Lemieux J; Thompson AM; Pritchard KI; Whelan TJ; Mukherjee SD; Chalchal HI; Oja CD; Tonkin KS; Bernstein V; Chen BE; Stambolic V
    J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25740979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of weight loss and metformin on cognition among breast cancer survivors: Evidence from the Reach for Health study.
    Hartman SJ; Nelson SH; Marinac CR; Natarajan L; Parker BA; Patterson RE
    Psychooncology; 2019 Aug; 28(8):1640-1646. PubMed ID: 31140202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of metformin as an adjuvant therapy to letrozole on estradiol and other biomarkers involved in the pathogenesis of breast cancer in overweight and obese postmenopausal women: a pilot study.
    El-Attar AA; Ibrahim OM; Alhassanin SA; Essa ES; Mostafa TM
    Eur J Clin Pharmacol; 2023 Feb; 79(2):299-309. PubMed ID: 36562831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Metformin vs Placebo on Sex Hormones in Canadian Cancer Trials Group MA.32.
    Pimentel I; Chen BE; Lohmann AE; Ennis M; Ligibel J; Shepherd L; Hershman DL; Whelan T; Stambolic V; Mayer I; Hobday T; Lemieux J; Thompson A; Rastogi P; Gelmon K; Rea D; Rabaglio M; Ellard S; Mates M; Bedard P; Pitre L; Vandenberg T; Dowling RJO; Parulekar W; Goodwin PJ
    J Natl Cancer Inst; 2021 Feb; 113(2):192-198. PubMed ID: 33527137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Favorable changes in serum estrogens and other biologic factors after weight loss in breast cancer survivors who are overweight or obese.
    Rock CL; Pande C; Flatt SW; Ying C; Pakiz B; Parker BA; Williams K; Bardwell WA; Heath DD; Nichols JF
    Clin Breast Cancer; 2013 Jun; 13(3):188-95. PubMed ID: 23375717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weight Regain and Breast Cancer-Related Biomarkers Following an Exercise Intervention in Postmenopausal Women.
    Gonzalo-Encabo P; McNeil J; Pérez-López A; Valades D; Courneya KS; Friedenreich CM
    Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1260-1269. PubMed ID: 33737300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of prediagnostic circulating levels of cardiometabolic markers, testosterone and sex hormone-binding globulin with risk of breast cancer among normal weight postmenopausal women in the UK Biobank.
    Arthur RS; Dannenberg AJ; Rohan TE
    Int J Cancer; 2021 Jul; 149(1):42-57. PubMed ID: 33567105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a low fat versus a low carbohydrate weight loss dietary intervention on biomarkers of long term survival in breast cancer patients ('CHOICE'): study protocol.
    Sedlacek SM; Playdon MC; Wolfe P; McGinley JN; Wisthoff MR; Daeninck EA; Jiang W; Zhu Z; Thompson HJ
    BMC Cancer; 2011 Jul; 11():287. PubMed ID: 21733177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial.
    Feig DS; Donovan LE; Zinman B; Sanchez JJ; Asztalos E; Ryan EA; Fantus IG; Hutton E; Armson AB; Lipscombe LL; Simmons D; Barrett JFR; Karanicolas PJ; Tobin S; McIntyre HD; Tian SY; Tomlinson G; Murphy KE;
    Lancet Diabetes Endocrinol; 2020 Oct; 8(10):834-844. PubMed ID: 32946820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin for overweight women at midlife: a double-blind, randomized, controlled trial.
    Worsley R; Jane F; Robinson PJ; Bell RJ; Davis SR
    Climacteric; 2015 Apr; 18(2):270-7. PubMed ID: 25333776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of synbiotic on glycemic profile and sex hormones in overweight and obese breast cancer survivors following a weight-loss diet: A randomized, triple-blind, controlled trial.
    Raji Lahiji M; Najafi S; Janani L; Yazdani B; Razmpoosh E; Zarrati M
    Clin Nutr; 2021 Feb; 40(2):394-403. PubMed ID: 32698957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of baseline oestradiol serum concentration on the efficacy of anastrozole for preventing breast cancer in postmenopausal women at high risk: a case-control study of the IBIS-II prevention trial.
    Cuzick J; Chu K; Keevil B; Brentnall AR; Howell A; Zdenkowski N; Bonanni B; Loibl S; Holli K; Evans DG; Cummings S; Dowsett M
    Lancet Oncol; 2024 Jan; 25(1):108-116. PubMed ID: 38070530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol.
    Martinez JA; Chalasani P; Thomson CA; Roe D; Altbach M; Galons JP; Stopeck A; Thompson PA; Villa-Guillen DE; Chow HH
    BMC Cancer; 2016 Jul; 16():500. PubMed ID: 27430256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.
    Dodd JM; Grivell RM; Deussen AR; Hague WM
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD010564. PubMed ID: 30039871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.